As previously demonstrated in monkeys, a similar decrease in fasting C-peptide/insulin that precedes overt type 2 diabetes [48] was seen in our dysmetabolic monkeys, and pioglitazone treatment significant increased this ratio (Fig 2A). The gene discussed is INS; the disease is type 2 diabetes mellitus.